nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Conjugated Estrogens—osteoporosis	0.365	0.532	CbGbCtD
Penicillamine—SLCO1B1—Estradiol—osteoporosis	0.32	0.468	CbGbCtD
Penicillamine—Anaemia—Etidronic acid—osteoporosis	0.000997	0.00317	CcSEcCtD
Penicillamine—Hypersensitivity—Calcium Acetate—osteoporosis	0.000988	0.00314	CcSEcCtD
Penicillamine—Angiopathy—Estropipate—osteoporosis	0.000973	0.00309	CcSEcCtD
Penicillamine—Abdominal pain upper—Zoledronate—osteoporosis	0.000971	0.00309	CcSEcCtD
Penicillamine—Leukopenia—Etidronic acid—osteoporosis	0.000966	0.00307	CcSEcCtD
Penicillamine—Lymphadenopathy—Estradiol—osteoporosis	0.000961	0.00305	CcSEcCtD
Penicillamine—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.000949	0.00302	CcSEcCtD
Penicillamine—Alopecia—Estropipate—osteoporosis	0.000947	0.00301	CcSEcCtD
Penicillamine—Thrombophlebitis—Estradiol—osteoporosis	0.000947	0.00301	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Estradiol—osteoporosis	0.000942	0.003	CcSEcCtD
Penicillamine—Angiopathy—Raloxifene—osteoporosis	0.000942	0.003	CcSEcCtD
Penicillamine—Mental disorder—Estropipate—osteoporosis	0.000939	0.00299	CcSEcCtD
Penicillamine—Muscular weakness—Zoledronate—osteoporosis	0.000938	0.00298	CcSEcCtD
Penicillamine—Hepatic function abnormal—Estradiol—osteoporosis	0.000938	0.00298	CcSEcCtD
Penicillamine—Alopecia—Alendronate—osteoporosis	0.000933	0.00297	CcSEcCtD
Penicillamine—Angiopathy—Ibandronate—osteoporosis	0.000933	0.00297	CcSEcCtD
Penicillamine—Asthma—Zoledronate—osteoporosis	0.000919	0.00292	CcSEcCtD
Penicillamine—Arthralgia—Etidronic acid—osteoporosis	0.000919	0.00292	CcSEcCtD
Penicillamine—Diarrhoea—Calcium Acetate—osteoporosis	0.000918	0.00292	CcSEcCtD
Penicillamine—Alopecia—Ibandronate—osteoporosis	0.000909	0.00289	CcSEcCtD
Penicillamine—Mental disorder—Ibandronate—osteoporosis	0.000901	0.00286	CcSEcCtD
Penicillamine—Dysgeusia—Alendronate—osteoporosis	0.0009	0.00286	CcSEcCtD
Penicillamine—Hepatobiliary disease—Risedronate—osteoporosis	0.000893	0.00284	CcSEcCtD
Penicillamine—Injury—Estradiol—osteoporosis	0.000892	0.00284	CcSEcCtD
Penicillamine—Asthma—Conjugated Estrogens—osteoporosis	0.000885	0.00281	CcSEcCtD
Penicillamine—Renal failure—Pamidronate—osteoporosis	0.000882	0.0028	CcSEcCtD
Penicillamine—Dysgeusia—Ibandronate—osteoporosis	0.000877	0.00279	CcSEcCtD
Penicillamine—Stomatitis—Pamidronate—osteoporosis	0.000875	0.00278	CcSEcCtD
Penicillamine—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000874	0.00278	CcSEcCtD
Penicillamine—Pancytopenia—Zoledronate—osteoporosis	0.000873	0.00278	CcSEcCtD
Penicillamine—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000869	0.00276	CcSEcCtD
Penicillamine—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000868	0.00276	CcSEcCtD
Penicillamine—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000858	0.00273	CcSEcCtD
Penicillamine—Dysgeusia—Calcitriol—osteoporosis	0.000858	0.00273	CcSEcCtD
Penicillamine—Haematuria—Pamidronate—osteoporosis	0.000856	0.00272	CcSEcCtD
Penicillamine—Vomiting—Calcium Acetate—osteoporosis	0.000853	0.00271	CcSEcCtD
Penicillamine—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000852	0.00271	CcSEcCtD
Penicillamine—Haemoglobin—Risedronate—osteoporosis	0.000852	0.00271	CcSEcCtD
Penicillamine—Anaemia—Alendronate—osteoporosis	0.00085	0.0027	CcSEcCtD
Penicillamine—Haemorrhage—Risedronate—osteoporosis	0.000847	0.00269	CcSEcCtD
Penicillamine—Agranulocytosis—Pamidronate—osteoporosis	0.000837	0.00266	CcSEcCtD
Penicillamine—Urinary tract disorder—Risedronate—osteoporosis	0.000837	0.00266	CcSEcCtD
Penicillamine—Urethral disorder—Risedronate—osteoporosis	0.000831	0.00264	CcSEcCtD
Penicillamine—Anaemia—Ibandronate—osteoporosis	0.000827	0.00263	CcSEcCtD
Penicillamine—Haemoglobin—Pamidronate—osteoporosis	0.00081	0.00257	CcSEcCtD
Penicillamine—Renal failure—Zoledronate—osteoporosis	0.000806	0.00256	CcSEcCtD
Penicillamine—Haemorrhage—Pamidronate—osteoporosis	0.000806	0.00256	CcSEcCtD
Penicillamine—Agitation—Calcitriol—osteoporosis	0.000805	0.00256	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000802	0.00255	CcSEcCtD
Penicillamine—Stomatitis—Zoledronate—osteoporosis	0.000799	0.00254	CcSEcCtD
Penicillamine—Nausea—Calcium Acetate—osteoporosis	0.000797	0.00253	CcSEcCtD
Penicillamine—Urinary tract disorder—Pamidronate—osteoporosis	0.000796	0.00253	CcSEcCtD
Penicillamine—Arthralgia—Estropipate—osteoporosis	0.000795	0.00253	CcSEcCtD
Penicillamine—Anxiety—Estropipate—osteoporosis	0.000792	0.00252	CcSEcCtD
Penicillamine—Tinnitus—Risedronate—osteoporosis	0.00079	0.00251	CcSEcCtD
Penicillamine—Urethral disorder—Pamidronate—osteoporosis	0.00079	0.00251	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000789	0.00251	CcSEcCtD
Penicillamine—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000789	0.00251	CcSEcCtD
Penicillamine—Haematuria—Zoledronate—osteoporosis	0.000781	0.00249	CcSEcCtD
Penicillamine—Renal failure—Conjugated Estrogens—osteoporosis	0.000776	0.00247	CcSEcCtD
Penicillamine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.000774	0.00246	CcSEcCtD
Penicillamine—Arthralgia—Raloxifene—osteoporosis	0.00077	0.00245	CcSEcCtD
Penicillamine—Angiopathy—Risedronate—osteoporosis	0.000769	0.00244	CcSEcCtD
Penicillamine—Alopecia—Ethinyl Estradiol—osteoporosis	0.000768	0.00244	CcSEcCtD
Penicillamine—Agranulocytosis—Zoledronate—osteoporosis	0.000765	0.00243	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000764	0.00243	CcSEcCtD
Penicillamine—Arthralgia—Ibandronate—osteoporosis	0.000762	0.00242	CcSEcCtD
Penicillamine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000761	0.00242	CcSEcCtD
Penicillamine—Anxiety—Ibandronate—osteoporosis	0.000759	0.00241	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000757	0.00241	CcSEcCtD
Penicillamine—Abdominal pain upper—Estradiol—osteoporosis	0.000749	0.00238	CcSEcCtD
Penicillamine—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000746	0.00237	CcSEcCtD
Penicillamine—Anxiety—Calcitriol—osteoporosis	0.000743	0.00236	CcSEcCtD
Penicillamine—Mental disorder—Risedronate—osteoporosis	0.000742	0.00236	CcSEcCtD
Penicillamine—Skin disorder—Estropipate—osteoporosis	0.00074	0.00235	CcSEcCtD
Penicillamine—Angiopathy—Pamidronate—osteoporosis	0.000731	0.00232	CcSEcCtD
Penicillamine—Urinary tract disorder—Zoledronate—osteoporosis	0.000727	0.00231	CcSEcCtD
Penicillamine—Thrombocytopenia—Raloxifene—osteoporosis	0.000722	0.0023	CcSEcCtD
Penicillamine—Urethral disorder—Zoledronate—osteoporosis	0.000721	0.00229	CcSEcCtD
Penicillamine—Skin disorder—Raloxifene—osteoporosis	0.000717	0.00228	CcSEcCtD
Penicillamine—Alopecia—Pamidronate—osteoporosis	0.000712	0.00226	CcSEcCtD
Penicillamine—Skin disorder—Ibandronate—osteoporosis	0.00071	0.00226	CcSEcCtD
Penicillamine—Asthma—Estradiol—osteoporosis	0.000708	0.00225	CcSEcCtD
Penicillamine—Nausea—Ergocalciferol—osteoporosis	0.000704	0.00224	CcSEcCtD
Penicillamine—Urticaria—Etidronic acid—osteoporosis	0.0007	0.00222	CcSEcCtD
Penicillamine—Skin disorder—Calcitriol—osteoporosis	0.000695	0.00221	CcSEcCtD
Penicillamine—Pancreatitis—Estradiol—osteoporosis	0.000695	0.00221	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000694	0.00221	CcSEcCtD
Penicillamine—Dysgeusia—Pamidronate—osteoporosis	0.000687	0.00218	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000684	0.00217	CcSEcCtD
Penicillamine—Anaemia—Risedronate—osteoporosis	0.000682	0.00217	CcSEcCtD
Penicillamine—Anorexia—Calcitriol—osteoporosis	0.000682	0.00217	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000672	0.00214	CcSEcCtD
Penicillamine—Angiopathy—Zoledronate—osteoporosis	0.000668	0.00212	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000666	0.00212	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000652	0.00207	CcSEcCtD
Penicillamine—Alopecia—Zoledronate—osteoporosis	0.00065	0.00207	CcSEcCtD
Penicillamine—Hypersensitivity—Etidronic acid—osteoporosis	0.000649	0.00206	CcSEcCtD
Penicillamine—Anaemia—Pamidronate—osteoporosis	0.000648	0.00206	CcSEcCtD
Penicillamine—Mental disorder—Zoledronate—osteoporosis	0.000645	0.00205	CcSEcCtD
Penicillamine—Agitation—Pamidronate—osteoporosis	0.000644	0.00205	CcSEcCtD
Penicillamine—Angiopathy—Conjugated Estrogens—osteoporosis	0.000643	0.00204	CcSEcCtD
Penicillamine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000642	0.00204	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00064	0.00203	CcSEcCtD
Penicillamine—Decreased appetite—Ibandronate—osteoporosis	0.000635	0.00202	CcSEcCtD
Penicillamine—Arthralgia—Risedronate—osteoporosis	0.000628	0.002	CcSEcCtD
Penicillamine—Leukopenia—Pamidronate—osteoporosis	0.000628	0.002	CcSEcCtD
Penicillamine—Dysgeusia—Zoledronate—osteoporosis	0.000627	0.00199	CcSEcCtD
Penicillamine—Alopecia—Conjugated Estrogens—osteoporosis	0.000626	0.00199	CcSEcCtD
Penicillamine—Anxiety—Risedronate—osteoporosis	0.000626	0.00199	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000624	0.00198	CcSEcCtD
Penicillamine—Decreased appetite—Calcitriol—osteoporosis	0.000622	0.00198	CcSEcCtD
Penicillamine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000621	0.00197	CcSEcCtD
Penicillamine—Neuropathy peripheral—Estradiol—osteoporosis	0.000619	0.00197	CcSEcCtD
Penicillamine—Urticaria—Estropipate—osteoporosis	0.000605	0.00192	CcSEcCtD
Penicillamine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000604	0.00192	CcSEcCtD
Penicillamine—Diarrhoea—Etidronic acid—osteoporosis	0.000602	0.00192	CcSEcCtD
Penicillamine—Haematuria—Estradiol—osteoporosis	0.000602	0.00192	CcSEcCtD
Penicillamine—Body temperature increased—Estropipate—osteoporosis	0.000602	0.00191	CcSEcCtD
Penicillamine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.0006	0.00191	CcSEcCtD
Penicillamine—Hepatobiliary disease—Estradiol—osteoporosis	0.000597	0.0019	CcSEcCtD
Penicillamine—Arthralgia—Pamidronate—osteoporosis	0.000597	0.0019	CcSEcCtD
Penicillamine—Urticaria—Alendronate—osteoporosis	0.000596	0.0019	CcSEcCtD
Penicillamine—Anxiety—Pamidronate—osteoporosis	0.000595	0.00189	CcSEcCtD
Penicillamine—Body temperature increased—Alendronate—osteoporosis	0.000593	0.00189	CcSEcCtD
Penicillamine—Anaemia—Zoledronate—osteoporosis	0.000592	0.00188	CcSEcCtD
Penicillamine—Agitation—Zoledronate—osteoporosis	0.000589	0.00187	CcSEcCtD
Penicillamine—Skin disorder—Risedronate—osteoporosis	0.000585	0.00186	CcSEcCtD
Penicillamine—Body temperature increased—Raloxifene—osteoporosis	0.000583	0.00185	CcSEcCtD
Penicillamine—Urticaria—Ibandronate—osteoporosis	0.00058	0.00185	CcSEcCtD
Penicillamine—Body temperature increased—Ibandronate—osteoporosis	0.000577	0.00184	CcSEcCtD
Penicillamine—Leukopenia—Zoledronate—osteoporosis	0.000573	0.00182	CcSEcCtD
Penicillamine—Haemoglobin—Estradiol—osteoporosis	0.00057	0.00181	CcSEcCtD
Penicillamine—Urticaria—Calcitriol—osteoporosis	0.000568	0.00181	CcSEcCtD
Penicillamine—Haemorrhage—Estradiol—osteoporosis	0.000567	0.0018	CcSEcCtD
Penicillamine—Body temperature increased—Calcitriol—osteoporosis	0.000565	0.0018	CcSEcCtD
Penicillamine—Hypersensitivity—Estropipate—osteoporosis	0.000561	0.00178	CcSEcCtD
Penicillamine—Thrombocytopenia—Pamidronate—osteoporosis	0.00056	0.00178	CcSEcCtD
Penicillamine—Urinary tract disorder—Estradiol—osteoporosis	0.00056	0.00178	CcSEcCtD
Penicillamine—Vomiting—Etidronic acid—osteoporosis	0.00056	0.00178	CcSEcCtD
Penicillamine—Urethral disorder—Estradiol—osteoporosis	0.000556	0.00177	CcSEcCtD
Penicillamine—Rash—Etidronic acid—osteoporosis	0.000555	0.00177	CcSEcCtD
Penicillamine—Dermatitis—Etidronic acid—osteoporosis	0.000555	0.00176	CcSEcCtD
Penicillamine—Hypersensitivity—Alendronate—osteoporosis	0.000553	0.00176	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000548	0.00174	CcSEcCtD
Penicillamine—Anorexia—Pamidronate—osteoporosis	0.000546	0.00173	CcSEcCtD
Penicillamine—Arthralgia—Zoledronate—osteoporosis	0.000545	0.00173	CcSEcCtD
Penicillamine—Anxiety—Zoledronate—osteoporosis	0.000543	0.00173	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000542	0.00172	CcSEcCtD
Penicillamine—Hypersensitivity—Ibandronate—osteoporosis	0.000538	0.00171	CcSEcCtD
Penicillamine—Tinnitus—Estradiol—osteoporosis	0.000529	0.00168	CcSEcCtD
Penicillamine—Hypersensitivity—Calcitriol—osteoporosis	0.000527	0.00168	CcSEcCtD
Penicillamine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000525	0.00167	CcSEcCtD
Penicillamine—Anxiety—Conjugated Estrogens—osteoporosis	0.000523	0.00166	CcSEcCtD
Penicillamine—Nausea—Etidronic acid—osteoporosis	0.000523	0.00166	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000521	0.00166	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000521	0.00166	CcSEcCtD
Penicillamine—Diarrhoea—Estropipate—osteoporosis	0.000521	0.00166	CcSEcCtD
Penicillamine—Angiopathy—Estradiol—osteoporosis	0.000514	0.00164	CcSEcCtD
Penicillamine—Diarrhoea—Alendronate—osteoporosis	0.000513	0.00163	CcSEcCtD
Penicillamine—Thrombocytopenia—Zoledronate—osteoporosis	0.000512	0.00163	CcSEcCtD
Penicillamine—Skin disorder—Zoledronate—osteoporosis	0.000508	0.00161	CcSEcCtD
Penicillamine—Diarrhoea—Raloxifene—osteoporosis	0.000505	0.00161	CcSEcCtD
Penicillamine—Alopecia—Estradiol—osteoporosis	0.000501	0.00159	CcSEcCtD
Penicillamine—Diarrhoea—Ibandronate—osteoporosis	0.0005	0.00159	CcSEcCtD
Penicillamine—Anorexia—Zoledronate—osteoporosis	0.000498	0.00158	CcSEcCtD
Penicillamine—Decreased appetite—Pamidronate—osteoporosis	0.000497	0.00158	CcSEcCtD
Penicillamine—Mental disorder—Estradiol—osteoporosis	0.000497	0.00158	CcSEcCtD
Penicillamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000491	0.00156	CcSEcCtD
Penicillamine—Diarrhoea—Calcitriol—osteoporosis	0.000489	0.00156	CcSEcCtD
Penicillamine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000489	0.00155	CcSEcCtD
Penicillamine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000488	0.00155	CcSEcCtD
Penicillamine—Vomiting—Estropipate—osteoporosis	0.000484	0.00154	CcSEcCtD
Penicillamine—Dysgeusia—Estradiol—osteoporosis	0.000483	0.00154	CcSEcCtD
Penicillamine—Rash—Estropipate—osteoporosis	0.00048	0.00153	CcSEcCtD
Penicillamine—Dermatitis—Estropipate—osteoporosis	0.00048	0.00153	CcSEcCtD
Penicillamine—Anorexia—Conjugated Estrogens—osteoporosis	0.00048	0.00153	CcSEcCtD
Penicillamine—Urticaria—Risedronate—osteoporosis	0.000478	0.00152	CcSEcCtD
Penicillamine—Vomiting—Alendronate—osteoporosis	0.000477	0.00152	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000476	0.00151	CcSEcCtD
Penicillamine—Body temperature increased—Risedronate—osteoporosis	0.000476	0.00151	CcSEcCtD
Penicillamine—Rash—Alendronate—osteoporosis	0.000473	0.0015	CcSEcCtD
Penicillamine—Dermatitis—Alendronate—osteoporosis	0.000473	0.0015	CcSEcCtD
Penicillamine—Vomiting—Raloxifene—osteoporosis	0.000469	0.00149	CcSEcCtD
Penicillamine—Rash—Raloxifene—osteoporosis	0.000465	0.00148	CcSEcCtD
Penicillamine—Dermatitis—Raloxifene—osteoporosis	0.000465	0.00148	CcSEcCtD
Penicillamine—Vomiting—Ibandronate—osteoporosis	0.000464	0.00148	CcSEcCtD
Penicillamine—Rash—Ibandronate—osteoporosis	0.000461	0.00146	CcSEcCtD
Penicillamine—Dermatitis—Ibandronate—osteoporosis	0.00046	0.00146	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000459	0.00146	CcSEcCtD
Penicillamine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000455	0.00145	CcSEcCtD
Penicillamine—Vomiting—Calcitriol—osteoporosis	0.000455	0.00145	CcSEcCtD
Penicillamine—Decreased appetite—Zoledronate—osteoporosis	0.000454	0.00145	CcSEcCtD
Penicillamine—Agitation—Estradiol—osteoporosis	0.000454	0.00144	CcSEcCtD
Penicillamine—Nausea—Estropipate—osteoporosis	0.000452	0.00144	CcSEcCtD
Penicillamine—Body temperature increased—Pamidronate—osteoporosis	0.000452	0.00144	CcSEcCtD
Penicillamine—Rash—Calcitriol—osteoporosis	0.000451	0.00143	CcSEcCtD
Penicillamine—Dermatitis—Calcitriol—osteoporosis	0.00045	0.00143	CcSEcCtD
Penicillamine—Nausea—Alendronate—osteoporosis	0.000446	0.00142	CcSEcCtD
Penicillamine—Hypersensitivity—Risedronate—osteoporosis	0.000444	0.00141	CcSEcCtD
Penicillamine—Nausea—Raloxifene—osteoporosis	0.000438	0.00139	CcSEcCtD
Penicillamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000438	0.00139	CcSEcCtD
Penicillamine—Nausea—Ibandronate—osteoporosis	0.000434	0.00138	CcSEcCtD
Penicillamine—Nausea—Calcitriol—osteoporosis	0.000425	0.00135	CcSEcCtD
Penicillamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000422	0.00134	CcSEcCtD
Penicillamine—Hypersensitivity—Pamidronate—osteoporosis	0.000422	0.00134	CcSEcCtD
Penicillamine—Arthralgia—Estradiol—osteoporosis	0.00042	0.00134	CcSEcCtD
Penicillamine—Anxiety—Estradiol—osteoporosis	0.000419	0.00133	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000417	0.00133	CcSEcCtD
Penicillamine—Urticaria—Zoledronate—osteoporosis	0.000415	0.00132	CcSEcCtD
Penicillamine—Body temperature increased—Zoledronate—osteoporosis	0.000413	0.00131	CcSEcCtD
Penicillamine—Diarrhoea—Risedronate—osteoporosis	0.000412	0.00131	CcSEcCtD
Penicillamine—Urticaria—Conjugated Estrogens—osteoporosis	0.0004	0.00127	CcSEcCtD
Penicillamine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000398	0.00127	CcSEcCtD
Penicillamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000393	0.00125	CcSEcCtD
Penicillamine—Diarrhoea—Pamidronate—osteoporosis	0.000392	0.00125	CcSEcCtD
Penicillamine—Skin disorder—Estradiol—osteoporosis	0.000391	0.00124	CcSEcCtD
Penicillamine—Rash—Ethinyl Estradiol—osteoporosis	0.000389	0.00124	CcSEcCtD
Penicillamine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000389	0.00124	CcSEcCtD
Penicillamine—Hypersensitivity—Zoledronate—osteoporosis	0.000385	0.00122	CcSEcCtD
Penicillamine—Vomiting—Risedronate—osteoporosis	0.000383	0.00122	CcSEcCtD
Penicillamine—Rash—Risedronate—osteoporosis	0.00038	0.00121	CcSEcCtD
Penicillamine—Dermatitis—Risedronate—osteoporosis	0.000379	0.00121	CcSEcCtD
Penicillamine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000371	0.00118	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000367	0.00117	CcSEcCtD
Penicillamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000367	0.00117	CcSEcCtD
Penicillamine—Vomiting—Pamidronate—osteoporosis	0.000364	0.00116	CcSEcCtD
Penicillamine—Rash—Pamidronate—osteoporosis	0.000361	0.00115	CcSEcCtD
Penicillamine—Dermatitis—Pamidronate—osteoporosis	0.000361	0.00115	CcSEcCtD
Penicillamine—Diarrhoea—Zoledronate—osteoporosis	0.000358	0.00114	CcSEcCtD
Penicillamine—Nausea—Risedronate—osteoporosis	0.000358	0.00114	CcSEcCtD
Penicillamine—Decreased appetite—Estradiol—osteoporosis	0.00035	0.00111	CcSEcCtD
Penicillamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000344	0.0011	CcSEcCtD
Penicillamine—Nausea—Pamidronate—osteoporosis	0.00034	0.00108	CcSEcCtD
Penicillamine—Vomiting—Zoledronate—osteoporosis	0.000332	0.00106	CcSEcCtD
Penicillamine—Rash—Zoledronate—osteoporosis	0.00033	0.00105	CcSEcCtD
Penicillamine—Dermatitis—Zoledronate—osteoporosis	0.000329	0.00105	CcSEcCtD
Penicillamine—Vomiting—Conjugated Estrogens—osteoporosis	0.00032	0.00102	CcSEcCtD
Penicillamine—Urticaria—Estradiol—osteoporosis	0.00032	0.00102	CcSEcCtD
Penicillamine—Body temperature increased—Estradiol—osteoporosis	0.000318	0.00101	CcSEcCtD
Penicillamine—Rash—Conjugated Estrogens—osteoporosis	0.000317	0.00101	CcSEcCtD
Penicillamine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000317	0.00101	CcSEcCtD
Penicillamine—Nausea—Zoledronate—osteoporosis	0.000311	0.000987	CcSEcCtD
Penicillamine—Nausea—Conjugated Estrogens—osteoporosis	0.000299	0.000951	CcSEcCtD
Penicillamine—Hypersensitivity—Estradiol—osteoporosis	0.000297	0.000944	CcSEcCtD
Penicillamine—Diarrhoea—Estradiol—osteoporosis	0.000276	0.000876	CcSEcCtD
Penicillamine—Vomiting—Estradiol—osteoporosis	0.000256	0.000814	CcSEcCtD
Penicillamine—Rash—Estradiol—osteoporosis	0.000254	0.000808	CcSEcCtD
Penicillamine—Dermatitis—Estradiol—osteoporosis	0.000254	0.000807	CcSEcCtD
Penicillamine—Nausea—Estradiol—osteoporosis	0.000239	0.000761	CcSEcCtD
